Entrada Therapeutics, Inc. (TRDA)
10.16
+0.09
(+0.89%)
USD |
NASDAQ |
Dec 04, 16:00
10.18
+0.02
(+0.20%)
After-Hours: 20:00
Entrada Therapeutics Market Cap: 388.31M for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Janux Therapeutics, Inc. | 986.42M |
| NovaBay Pharmaceuticals, Inc. | 137.35M |
| Palatin Technologies, Inc. | 20.44M |
| Theriva Biologics, Inc. | 8.152M |
| Oragenics, Inc. | 0.7008M |
Market Cap Related Metrics
| PS Ratio | 6.892 |
| Price to Book Value | 1.140 |
| Price | 10.16 |
| Earnings Yield | -24.64% |